ExploreWatchlistsPricing
  1. JP-listed companies
  2. ZERIA PHARMCEUTICAL CO., LTD.
  3. Financials
  4. Stockholders' equity

ZERIA PHARMCEUTICAL CO., LTD. (4559)

Market cap
¥124.2B
P/E ratio
10.3x
Japanese pharmaceutical company that develops and sells prescription drugs, over-the-counter medications, and health products through multiple subsidiaries worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 2026108,604+20.94%
Mar 31, 202589,797+12.49%
Mar 31, 202479,829+21.54%
Mar 31, 202365,681+19.22%
Mar 31, 202255,092-1.94%
Mar 31, 202156,180+6.65%
Mar 31, 202052,679-11.24%
Mar 31, 201959,348-9.66%
Mar 31, 201865,696+3.45%
Mar 31, 201763,505-0.88%
Mar 31, 201664,067+2.39%
Mar 31, 201562,571+6.53%
Mar 31, 201458,735

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat